Context Therapeutics
Focus: Context Therapeutics is a Philadelphia-based biotech focused on developing treatments for hormone-driven cancers, particularly in oncology and endocrinology indications.
Profile data last refreshed 7h ago · AI intelligence enriched 2mo ago
Open Jobs
4+4 this month
Stable — net +4 jobs in 30d
4 added, 0 removed. Backfill posture.
Should You Work at Context Therapeutics?
AI assessmentSuitable for early-stage oncology specialists willing to accept pre-revenue risk for focused scientific impact in a niche therapeutic area.
Why Work Here
- Focused pipeline with 8 active clinical programs across Phase 1/2 in high-unmet-need areas (breast cancer, ovarian cancer, endometrial cancer)
- Strong H1B sponsorship track record (22 approvals, 1 denial in 2023) suggests visa-friendly hiring practice
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
9 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Letrozole
Metastatic Breast CancerClinical Trials (1)
NCT04872608A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer
Phase 1Help build intelligence for Context Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.